| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8238527 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 6 Pages |
Abstract
No survival improvement could be demonstrated after changing the treatment policy to high-dose cisplatin-based, conventionally fractionated conformal chemoradiotherapy. Female gender and older age might predict for better outcomes.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Shao Hui M.Sc., Gina M.Math., James M.D., Bernard M.D., John M.D., Rebecca M.D., Andrew M.D., Jolie M.D.,